Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/16857820

Clin. Cancer Res. 2006 Jul 15 12 14 Pt 2 4416s-4420s

Download in:

View as

Triples

General Info

PMID
16857820